Evoq Remedies
Evoq Remedies Share Price Chart
Evoq Remedies last traded at ₹1.64 (2026-10-13). Over the past month the stock moved +6.5%, three months the stock moved -53.0%, year the stock moved -55.6%. Its closing range over 52 weeks is ₹1.40 – ₹5.97, with the latest close 72.5% below the high.
Closing prices up to 2026-10-13.
About Evoq Remedies
Incorporated in 2010, EVOQ Remedies Ltd is in the pharmaceutical business.[1]
Business Overview:[1] EVOQRL deals in the trading of the pharma products and commission agent in pharma products, etc.
Fundamentals
Quarterly Results
In the latest quarter (Mar 2026), Evoq Remedies reported sales of ₹0.00 crore (-100.0%) and net profit of ₹-0.29 crore (-176.3%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 0.00 | -0.50 | – | -0.29 | -0.12 |
| Sep 2025 | 25.51 | -0.95 | -3.72 | 0.05 | 0.02 |
| Mar 2025 | 11.76 | -0.60 | -5.10 | 1.71 | 0.69 |
| Sep 2024 | 0.00 | -1.63 | – | -1.62 | -0.65 |
| Mar 2024 | 0.15 | -1.72 | -1,146.67 | 0.38 | 0.28 |
| Sep 2023 | 3.90 | 0.07 | 1.79 | 0.05 | 0.04 |
| Mar 2023 | 4.60 | -4.04 | -87.83 | 1.31 | 0.96 |
| Sep 2022 | 15.79 | 0.31 | 1.96 | 0.31 | 0.23 |
| Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Sales growth | +66.7% | -20.9% | -98.7% | -100.0% | +155.7% | +554.1% | -100.0% |
| Operating profit growth | -484.8% | -90.4% | -335.6% | -625.8% | – | -1457.1% | – |
| Net profit growth | +61.7% | -93.2% | +5.6% | -622.6% | +30.5% | +0.0% | -176.3% |
| EPS growth | -99.9% | -100.0% | +7.7% | -382.6% | -28.1% | -50.0% | -142.9% |
| OPM % | -87.8% | 1.8% | -1146.7% | – | -5.1% | -3.7% | – |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), Evoq Remedies reported sales of ₹25.51 crore (+116.9%) and net profit of ₹-0.24 crore (-366.7%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 25.51 | -1.45 | -5.68 | -0.24 | -0.10 |
| Mar 2025 | 11.76 | -2.23 | -18.96 | 0.09 | 0.04 |
| Mar 2024 | 4.05 | -1.64 | -40.49 | 0.45 | 0.33 |
| Mar 2023 | 20.39 | -3.73 | -18.29 | 1.62 | 1.19 |
| Mar 2022 | 16.78 | 1.46 | 8.70 | 1.09 | 0.80 |
| Mar 2021 | 10.02 | 0.95 | 9.48 | 0.72 | 720.00 |
| Mar 2020 | 9.07 | 0.00 | 0.00 | 0.00 | 0.00 |
| Mar 2019 | 3.25 | 0.02 | 0.62 | 0.01 | 10.00 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Sales growth | +179.1% | +10.5% | +67.5% | +21.5% | -80.1% | +190.4% | +116.9% |
| Operating profit growth | -100.0% | – | +53.7% | -355.5% | – | – | – |
| Net profit growth | -100.0% | – | +51.4% | +48.6% | -72.2% | -80.0% | -366.7% |
| EPS growth | -100.0% | – | -99.9% | +48.7% | -72.3% | -87.9% | -350.0% |
| OPM % | 0.0% | 9.5% | 8.7% | -18.3% | -40.5% | -19.0% | -5.7% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for Evoq Remedies.
Get Free AI Stock Analysis FREE →Latest News
No recent news available for Evoq Remedies.
Frequently Asked Questions
What is the share price of Evoq Remedies today?
Evoq Remedies shares were last quoted at ₹1.64 (+0.0% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Evoq Remedies?
Evoq Remedies has a price-to-earnings (P/E) ratio of -14.60 and a price-to-book (P/B) ratio of 0.08. The industry P/E is 53.33.
What is the 52-week high and low of Evoq Remedies?
The 52-week high of Evoq Remedies is ₹6.11 and the 52-week low is ₹1.35.
What is the market cap of Evoq Remedies?
The market capitalisation of Evoq Remedies is about ₹3.64 crore.
How did Evoq Remedies perform in its latest quarterly results?
In the latest quarter (Mar 2026), Evoq Remedies reported sales of ₹0.00 crore (-100.0%) and net profit of ₹-0.29 crore (-176.3%), compared with the same quarter last year.
Is Evoq Remedies a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Evoq Remedies has a 3-year ROE of 0.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in Evoq Remedies?
Promoters hold about 0.02% of Evoq Remedies.
Which sector does Evoq Remedies belong to?
Evoq Remedies belongs to the Pharmaceuticals & Drugs sector.